Clinical Trial Update: IRay to Treat Polypoidal Choroidal Vasculopathy (PCV) Secondary to Age-Related Macular Degeneration (AMD [NA]

View source ↗

Summary

Clinical trial update indicates the IRay device is being explored to treat polypoidal choroidal vasculopathy secondary to age-related macular degeneration; curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration
• Polypoidal Choroidal Vasculopathy

Drugs mentioned

• IRay

Snippet

Sponsor: Oraya Therapeutics, Inc. | Conditions: Polypoidal Chorodial Vasculopathy, Age Related Macular Degeneration | NA | Status: UNKNOWN